Beranda › Sklerosis Multipel › California
Uji klinis Sklerosis Multipel di California
24 studi untuk Sklerosis Multipel mencari peserta di lokasi di California.
Kota di California
Teks studi resmi (Bahasa Inggris)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Fresno
- TG Therapeutics Investigational Trial Site, Newport Beach
- TG Therapeutics Investigational Trial Site, Orange
- dan 1 lainnya
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06433752Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- UC San Diego, La Jolla
Menerima pesertaFase 1/2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07477639Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Private Practice - Dr. Regina Berkovich- Site Number : 8400005, West Hollywood
Menerima pesertaFase 3
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0114, Loma Linda
- University of California Davis Health, Sacramento
Menerima pesertaFase 3
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06408259A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, La Jolla
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06680037A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford Neuroscience Health Center, Palo Alto
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT07304154Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
- University of California-San Francisco, San Francisco
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 64 · Wanita · Diperbarui 11 Agu 2026 · NCT06940323A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Fullerton Neuro and Headache Ctr, Fullerton
- Regina Berkovich MD PhD Inc, West Hollywood
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT07225504Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
- Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco
Menerima pesertaFase 1/2
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT05359653Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
- Byers Hall, San Francisco
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jun 2026 · NCT07510607Care in Multiple Sclerosis (MS)
- University of California, San Francisco, San Francisco
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT07011914ECoG BMI for Motor and Speech Control
- University of California San Francisco, San Francisco
Menerima peserta
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT03698149Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
- Stanford University, Redwood City
Menerima pesertaFase 1
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT07139743Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- University of California San Francisco, San Francisco
Menerima pesertaFase 2
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 11 Mar 2026 · NCT02521311A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
- Stanford Multiple Sclerosis Center, Palo Alto
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT06138132Central Vein Sign in Multiple Sclerosis Extension Study
- Cedars-Sinai Medical Center, Los Angeles
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 20 Feb 2026 · NCT07424027"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
- University of California, San Francisco, San Francisco
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Okt 2025 · NCT07222618Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- UCSF, San Francisco
- Stanford University, Stanford
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 2 Mei 2025 · NCT05395624Kesimpta (Ofatumumab) Pregnancy Registry
- University of California San Diego OTIS, La Jolla
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 14 Jan 2025 · NCT05634967Entire-body PET Scans for Multiple Sclerosis
- Brain Health Alliance, Ladera Ranch
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 25 hingga 55 · Semua jenis kelamin · Diperbarui 7 Jan 2025 · NCT04390009Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
- Novartis Investigative Site, La Jolla
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Wanita · Diperbarui 16 Mei 2024 · NCT04933552MS-ResearchBiomarkerS
- Cedars-Sinai Medical Center, Los Angeles
Menerima pesertaStudi observasionalSukarelawan sehat diterimaMenyebutkan pembayaran untuk peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Feb 2024 · NCT05204459Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.